ScholarIQanswers from OpenAlex & ORCID
Edie Weller
ResearcherPublications, citations & collaboration network
Edie Weller is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Edie Weller have?
ScholarIQindexed works
Edie Weller has 231 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Edie Weller have?
ScholarIQcitation count
Edie Weller has 16,553 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Edie Weller?
ScholarIQh-index
Edie Weller has an h-index of 60 in OpenAlex.
What is the i10-index of Edie Weller?
ScholarIQi10-index
Edie Weller has an i10-index of 116 in OpenAlex.
What is the OpenAlex record for Edie Weller?
ScholarIQopenalex
The OpenAlex for Edie Weller is on the source record.
What are the most-cited papers on Edie Weller?
ScholarIQmost cited works
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
Thomas M. Habermann, Edie Weller, Vicki A. Morrison, Randy D. Gascoyne, Peter A. Cassileth, Jeffrey Cohn, Shaker R. Dakhil, Bruce A. Woda, Richard I. Fisher, B. A. Peterson, Sandra J. Horning
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin, Xavier Leleu, Denis Caillot, Martine Escoffre, Bertrand Arnulf, Margaret Macro, Karim Belhadj, Laurent Garderet, Murielle Roussel, Catherine Payen, Claire Mathiot, Jean Paul Fermand, Nathalie Meuleman, Sandrine Rollet, Michelle E. Maglio, Andrea A. Zeytoonjian, Edie Weller, Nikhil C. Munshi, Kenneth C. Anderson, Paul G. Richardson, Thierry Façon, Hervé Avet‐Loiseau, Jean‐Luc Harousseau, Philippe Moreau
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Paul G. Richardson, Edie Weller, Sagar Lonial, Andrzej Jakubowiak, Sundar Jagannath, Noopur Raje, David Avigan, Wanling Xie, Irene M. Ghobrial, Robert Schlossman, Amitabha Mazumder, Nikhil C. Munshi, David H. Vesole, Robin Joyce, Jonathan L. Kaufman, Deborah Doss, Diane Warren, Laura Lunde, Sarah Kaster, Carol Delaney, Teru Hideshima, Constantine S. Mitsiades, Robert Knight, Dixie‐Lee Esseltine, Kenneth C. Anderson
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Paul G. Richardson, Robert Schlossman, Edie Weller, Teru Hideshima, Constantine S. Mitsiades, Faith E. Davies, Richard LeBlanc, Laurence Catley, Deborah Doss, Kathleen Kelly, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca L. Rich, Joan J. Ryoo, Dharminder Chauhan, Kathe Balinski, Jerome B. Zeldis, Kenneth C. Anderson
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro, Antonio Sacco, Patricia Maiso, Abdel Kareem Azab, Yu-Tzu Tai, Michaela R. Reagan, Feda Azab, Ludmila M. Flores, Federico Campigotto, Edie Weller, Kenneth C. Anderson, David T. Scadden, Irene M. Ghobrial